AnaptysBio (ANAB) PT Raised to $50 at Truist Securities on improved outlook for Jemperli
Tweet Send to a Friend
Truist Securities analyst John Lee raised the price target on AnaptysBio (NASDAQ: ANAB) to $50.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
